Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Mathew W. MacCumber"'
Autor:
Kyle S. Chan, Nitika Aggarwal, Shannon Lawson, Nick Boucher, Mathew W. MacCumber, Jeremy A. Lavine
Publikováno v:
Eye and Vision, Vol 11, Iss 1, Pp 1-6 (2024)
Abstract Background Geographic atrophy (GA) is a significant cause of vision loss in patients with age-related macular degeneration (AMD). Current treatments are limited to anti-complement drugs, which have limited efficacy to delay progression with
Externí odkaz:
https://doaj.org/article/ea4b171ff11e49d490f7343f69eef9cb
Autor:
Marco A. Zarbin, Mathew W. MacCumber, Helene Karcher, Eser Adiguzel, Andrew Mayhook, Andrew LaPrise, Ver L. Bilano, Franklin Igwe, Michael S. Ip, Charles C. Wykoff
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 5, Pp 1357-1368 (2024)
Abstract Introduction To assess real-world safety outcomes for adults with neovascular age-related macular degeneration (nAMD) treated with brolucizumab from the US-based IRIS® (Intelligent Research in Sight) Registry. Methods In this retrospective
Externí odkaz:
https://doaj.org/article/4bd8e9311ca342698e41e986dba8c257
Autor:
Mathew W. MacCumber, Charles C. Wykoff, Helene Karcher, Eser Adiguzel, Samriddhi Buxy Sinha, Saloni Vishwakarma, Andrew LaPrise, Franklin Igwe, Rita Freitas, Michael S. Ip, Marco A. Zarbin
Publikováno v:
Ophthalmology.
Autor:
Mathew W. MacCumber, Charles C. Wykoff, Helene Karcher, Eser Adiguzel, Samriddhi Buxy Sinha, Saloni Vishwakarma, Andrew LaPrise, Franklin Igwe, Rita Freitas, Michael S. Ip, Marco A. Zarbin
Publikováno v:
Ophthalmology.
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole
Autor:
Mathew W MacCumber, Adam R. Glassman, Raj K. Maturi, Maureen G. Maguire, Claire T. Calhoun, Calvin E. Mein, Lee M. Jampol, Wesley T. Beaulieu, Glenn J. Jaffe, Jennifer K. Sun, Soraya Rofagha, Clement K. Chan, Hani Salehi-Had, Daniel F. Martin
Publikováno v:
Ophthalmology. 128:1592-1603
Purpose To evaluate pneumatic vitreolysis (PVL) in eyes with vitreomacular traction (VMT) with and without full-thickness macular hole (FTMH). Design Two multicenter (28 sites) studies: a randomized clinical trial comparing PVL with observation (sham
Autor:
Omar Dajani, Anthony Wong, Alyssa Coleman, Emily A. Shepherd, Kenneth P. Wind, Mathew W. MacCumber
Publikováno v:
Retinal casesbrief reports.
To describe a case of vitreous seeding with tractional retinal detachment due to metastatic renal cell carcinoma (RCC) in a patient on systemic checkpoint inhibitors.Case Report.A 44-year-old Hispanic woman with a history of RCC with metastases to th
Autor:
Palak R. Patel, Jonathan Minkowski, Omar Dajani, Jacob Weber, Nick Boucher, Mathew W. MacCumber
Publikováno v:
Ophthalmology. Retina.
To examine the incidence of complications after posterior vitreous detachment (PVD) through an extended follow-up period and to identify patient-specific factors associated with a greater incidence of complication.Multicenter, retrospective observati
Publikováno v:
Retina. 41:505-509
Purpose Evaluate macular features on preoperative ocular coherence tomography as indicators of postoperative visual gain following vitrectomy for epiretinal membrane (ERM). Methods A retrospective chart review of 66 eyes that underwent vitrectomy wit
Autor:
Mark R. Barakat, Peter K. Kaiser, Arshad M. Khanani, Guruprasad B, Mathew W MacCumber, Neetu Agashivala, Thomas A. Albini, Marco A. Zarbin, Charles C. Wykoff, Justin S Yu
Publikováno v:
JAMA ophthalmology. 140(1)
Importance Limited data exist on the real-world safety outcomes of patients with neovascular age-related macular degeneration treated with brolucizumab (Beovu). Objective To determine the real-world incidence of intraocular inflammation (IOI), includ
Autor:
Mathew W. MacCumber, Justin S. Yu, Alexandros Sagkriotis, Guruprasad B, Bhavya Burugapalli, Xiaoyu Bi, Neetu Agashivala, Charles C. Wykoff
Publikováno v:
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
To evaluate treatment patterns and outcomes of patients in the United States who received antivascular endothelial growth factor (anti-VEGF) agents for wet age-related macular degeneration (AMD).Retrospective study PARTICIPANTS: Patients with wet AMD